457 related articles for article (PubMed ID: 35844506)
41. Immunogenic cell death inducers for enhanced cancer immunotherapy.
Li Y; Liu X; Zhang X; Pan W; Li N; Tang B
Chem Commun (Camb); 2021 Nov; 57(91):12087-12097. PubMed ID: 34714302
[TBL] [Abstract][Full Text] [Related]
42. Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity.
Li Y; Guo Y; Zhang K; Zhu R; Chen X; Zhang Z; Yang W
Adv Sci (Weinh); 2024 Jan; 11(3):e2306580. PubMed ID: 37984863
[TBL] [Abstract][Full Text] [Related]
43. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?
Yuan CS; Deng ZW; Qin D; Mu YZ; Chen XG; Liu Y
Acta Biomater; 2021 Apr; 125():1-28. PubMed ID: 33639310
[TBL] [Abstract][Full Text] [Related]
44. Immunogenic Cell Death-Based Cancer Vaccines.
Jin MZ; Wang XP
Front Immunol; 2021; 12():697964. PubMed ID: 34135914
[TBL] [Abstract][Full Text] [Related]
45. Activating Nanomedicines with Electromagnetic Energy for Deep-Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy.
Wang F; Pu K; Li J
Small Methods; 2023 May; 7(5):e2201083. PubMed ID: 36316270
[TBL] [Abstract][Full Text] [Related]
46. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.
Gao W; Wang X; Zhou Y; Wang X; Yu Y
Signal Transduct Target Ther; 2022 Jun; 7(1):196. PubMed ID: 35725836
[TBL] [Abstract][Full Text] [Related]
47. Immunogenicity of cancer cells: An overview.
Singh T; Bhattacharya M; Mavi AK; Gulati A; Rakesh ; Sharma NK; Gaur S; Kumar U
Cell Signal; 2024 Jan; 113():110952. PubMed ID: 38084844
[TBL] [Abstract][Full Text] [Related]
48. Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system.
Calvillo-Rodríguez KM; Lorenzo-Anota HY; Rodríguez-Padilla C; Martínez-Torres AC; Scott-Algara D
Front Immunol; 2023; 14():1294434. PubMed ID: 38077402
[TBL] [Abstract][Full Text] [Related]
49. Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions.
Lu J; He R; Liu Y; Zhang J; Xu H; Zhang T; Chen L; Yang G; Zhang J; Liu J; Chi H
Front Cell Dev Biol; 2024; 12():1416115. PubMed ID: 38887519
[TBL] [Abstract][Full Text] [Related]
50. Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer.
Ma J; Ramachandran M; Jin C; Quijano-Rubio C; Martikainen M; Yu D; Essand M
Cell Death Dis; 2020 Jan; 11(1):48. PubMed ID: 31969562
[TBL] [Abstract][Full Text] [Related]
51. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments.
Inoue H; Tani K
Cell Death Differ; 2014 Jan; 21(1):39-49. PubMed ID: 23832118
[TBL] [Abstract][Full Text] [Related]
52. The inducers of immunogenic cell death for tumor immunotherapy.
Li X
Tumori; 2018; 104(1):1-8. PubMed ID: 28967094
[TBL] [Abstract][Full Text] [Related]
53. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
[TBL] [Abstract][Full Text] [Related]
54. Photothermal MnO
Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
[TBL] [Abstract][Full Text] [Related]
55. MnO
Ding B; Zheng P; Jiang F; Zhao Y; Wang M; Chang M; Ma P; Lin J
Angew Chem Int Ed Engl; 2020 Sep; 59(38):16381-16384. PubMed ID: 32484598
[TBL] [Abstract][Full Text] [Related]
56. Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment.
Wang J; Ma J; Tai Z; Li L; Zhang T; Cheng T; Yu J; Zhu Q; Bao L; Chen Z
Int J Nanomedicine; 2023; 18():7149-7172. PubMed ID: 38059000
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms of immunogenic cell death and immune checkpoint blockade therapy.
Lin RA; Lin JK; Lin SY
Kaohsiung J Med Sci; 2021 Jun; 37(6):448-458. PubMed ID: 33636043
[TBL] [Abstract][Full Text] [Related]
58. Engineered nanomaterials for synergistic photo-immunotherapy.
Guo R; Wang S; Zhao L; Zong Q; Li T; Ling G; Zhang P
Biomaterials; 2022 Mar; 282():121425. PubMed ID: 35217344
[TBL] [Abstract][Full Text] [Related]
59. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate.
Lu Y; Xu F; Wang Y; Shi C; Sha Y; He G; Yao Q; Shao K; Sun W; Du J; Fan J; Peng X
Biomaterials; 2021 Nov; 278():121167. PubMed ID: 34624752
[TBL] [Abstract][Full Text] [Related]
60. Inducing immunogenic cell death in immuno-oncological therapies.
Ti D; Yan X; Wei J; Wu Z; Wang Y; Han W
Chin J Cancer Res; 2022 Feb; 34(1):1-10. PubMed ID: 35355932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
